- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT01414946
The Effect of Intravenous Nutrition in Patients Undergoing Abdominal Surgery
THE PROTEIN SPARING EFFECT OF PERIOPERATIVE NUTRITION: How Important is the Patient's Catabolic State Before Surgery and do we Need Glucose?
Loss of muscle protein and mass are the main causes of fatigue after bowel surgery which may result in a longer hospital stay and a higher rate of complications. This problem is especially important for patients after surgery for bowel cancer because cancer itself causes a waste of muscle protein. Anesthesiologists can decrease these negative effects of surgery by choosing the type of pain treatment (analgesia) and by giving nutrition (sugar and protein). Our group recently observed that optimal pain relief with epidural catheters (these are placed in the so called epidural space, which lies between the spine and the skin of the back) in combination with a low calorie protein diet intravenously (through the vein) maintains the body's protein stores after bowel surgery.
The goal of our new research program is to find out whether this protein saving effect depends on how protein depleted the patient is before surgery. In other words we would like to answer the question: do cancer patients who show protein wasting before the operation benefit more from feeding than patients who show no signs of protein wasting? A second goal of this program is to find out if we need to use sugar as part of the diet or whether the infusion of protein alone is sufficient. Just giving protein would make feeding not only easier but also would avoid the increase in the patient's own blood sugar during and after the operation, which typically occurs when sugar is given intravenously during that period.
Study Overview
Status
Conditions
Intervention / Treatment
Detailed Description
- Goals The overall goal of perioperative nutrition support is to abolish protein wasting and to promote anabolic processes by directing amino acids into protein synthesis rather than oxidation. Protein repletion and enhancement of anabolism appear to be particularly important in cancer patients who enter major abdominal surgery in a catabolic state.
Objectives The objectives of this research program are
- to examine whether the anabolic effects of hypocaloric nutrition depend on the degree of catabolism before the operation and thus identify patients who benefit the most from perioperative nutrition support (study I)
- to investigate whether excluding glucose from hypocaloric nutrition, i.e. infusing an isonitrogenous amount of amino acids without glucose avoids hyperglycemia and, thus, accentuates the patient's anabolic response to feeding (study II).
In order to confirm the validity of our assumptions we will perform two consecutive studies in two distinct patient populations. For the assessment of the patients' catabolic state and obtaining insight into the biochemical mechanisms, whereby the effects of nutrition are mediated, stable isotope tracer kinetics will be applied. Using primed continuous infusions of L-[1-13C]leucine and [6,6-2H2]glucose we will quantitate the whole body dynamics of protein and glucose metabolism, i.e. protein breakdown, amino acid oxidation, protein synthesis, glucose production and glucose uptake before and after surgery. A positive protein balance (difference between protein synthesis and protein breakdown) will be used as an indicator of anabolism. Anabolic processes at the organ level (liver, muscle), i.e. fractional synthesis rates of the acute phase proteins albumin and fibrinogen and muscle protein synthesis will be determined using L-[2H5]phenylalanine infusions. Skeletal muscle protein catabolism will be characterized by measuring the mRNA expression of ubiquitin and two of its key ligases in muscle (MAFbx/atrogen-1 and MuRF-1).
Study Type
Enrollment (Actual)
Phase
- Not Applicable
Contacts and Locations
Study Locations
-
-
Quebec
-
Montreal, Quebec, Canada, H3A 1A1
- Royal Victoria Hospital, McGill University Health Centre
-
-
Participation Criteria
Eligibility Criteria
Ages Eligible for Study
Accepts Healthy Volunteers
Genders Eligible for Study
Description
Inclusion Criteria:
- American Society of Anesthesiologists <3
- colorectal surgery for non-metastatic colorectal carcinoma including right and left hemicolectomy, transverse, subtotal and total colectomy, sigmoid resection
- ability to give informed consent
Exclusion Criteria:
- signs of severe malnutrition or obesity: body mass index <18 or >25 >10% involuntary body weight loss over the preceding 6 months serum albumin <21 g/L
- significant cardiorespiratory, hepatic, renal and neurological disease
- ingestion of drugs known to affect protein, glucose and lipid metabolism (for example steroids)
- musculoskeletal or neuromuscular disease
- severe anemia (hemoglobin <10 g/dL)
- pregnancy
- history of severe sciatica or back surgery or other conditions which
- contraindicate the use of epidural catheters
Study Plan
How is the study designed?
Design Details
- Primary Purpose: Treatment
- Allocation: Non-Randomized
- Interventional Model: Parallel Assignment
- Masking: Single
Arms and Interventions
Participant Group / Arm |
Intervention / Treatment |
---|---|
Experimental: Glucose and amino acids
Perioperative nutrition with glucose and amino acids
|
Glucose and amino acids intravenously starting 20 hours before the operation until the second postoperative day.
Glucose provides 50% and amino acids 20% of each patient's measured resting energy expenditure.
|
Active Comparator: Amino acids only
Perioperative nutrition with amino acids only
|
Amino acids intravenously starting 20 hours before the operation until the second postoperative day.
Amino acids providing 20% of each patient's measured resting energy expenditure.
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Time Frame |
---|---|
protein balance
Time Frame: two days after surgery
|
two days after surgery
|
Secondary Outcome Measures
Outcome Measure |
Time Frame |
---|---|
albumin synthesis
Time Frame: two days after surgery
|
two days after surgery
|
fibrinogen synthesis
Time Frame: two days after surgery
|
two days after surgery
|
total plasma protein synthesis
Time Frame: two days after surgery
|
two days after surgery
|
mRNA expression of ubiquitin
Time Frame: two days after surgery
|
two days after surgery
|
Collaborators and Investigators
Investigators
- Principal Investigator: Thomas Schricker, MD PhD, Department of Anaesthesia, McGill University Health Centre
Publications and helpful links
Study record dates
Study Major Dates
Study Start
Primary Completion (Actual)
Study Completion (Actual)
Study Registration Dates
First Submitted
First Submitted That Met QC Criteria
First Posted (Estimate)
Study Record Updates
Last Update Posted (Estimate)
Last Update Submitted That Met QC Criteria
Last Verified
More Information
Terms related to this study
Other Study ID Numbers
- CIHR-2011
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Postoperative Protein Catabolism
-
McGill University Health Centre/Research Institute...CompletedPostoperative Protein CatabolismCanada
-
Medical University of GdanskCompletedSepsis | Amino Acid Catabolism DisorderPoland
-
Rajavithi HospitalRecruitingPostoperative Outcomes | Whey Protein | Gynecological Cancer SurgeryThailand
-
Kartal Kosuyolu Yuksek Ihtisas Education and Research...CompletedPostoperative Complications | Cardiopulmonary Bypass | Procalcitonin | Outcome | Lactate | C-reactive Protein | Open Heart Surgery
-
General Hospital of Ningxia Medical UniversityCompletedPostoperative Complications | Cognitive Dysfunction | Inflammasomes | Pyrin Domain-Containing 3 ProteinChina
-
Ege UniversityCompletedPostoperative Cognitive Dysfunction | Brain Damage | Neuron Specific Enolase | Glial Fibrillary Acidic ProteinTurkey
-
Bispebjerg HospitalCompleted
-
Moroccan Society of SurgeryRecruitingAnastomotic Leak | Digestive System Neoplasm | C-Reactive ProteinMorocco
-
Kasper DideriksenUnknownMuscle Protein Synthesis | Meat Protein Supplements | Protein Absorption and Amino Acid AvailabilityDenmark
-
University of Illinois at Urbana-ChampaignCompletedMuscle Protein Synthesis | Protein MetabolismUnited States
Clinical Trials on Intravenous nutrition with glucose and amino acids
-
McGill University Health Centre/Research Institute...CompletedPostoperative Protein CatabolismCanada
-
Hospital Sant Joan de DeuFundació Sant Joan de Déu; Spanish National Health SystemCompletedInflammatory Response | Multi-organ FailureSpain
-
Maastricht University Medical CenterMaastricht University Medical CenterRecruitingCritical Illness | Muscle WastingNetherlands
-
The Hospital for Sick ChildrenCompletedParenteral Lysine Requirements | Parenteral FeedingsCanada
-
Hospital Universitari Son DuretaEspen; This research prize was funded by Nestle Nutrition Institute and by...CompletedModerate to Severe Trauma, as Defined by an | Injury Severity Score (ISS) > 12 Points Were Included in the Study.Spain
-
NICHD Neonatal Research NetworkNational Center for Research Resources (NCRR)CompletedSepsis | Infant, Small for Gestational Age | Infant, Premature | Infant, Low Birth Weight | Infant, NewbornUnited States
-
Abbott NutritionTerminatedAcute Lung Injury | Respiratory Distress Syndrome,AdultRussian Federation
-
Stanley Dudrick's Memorial HospitalRecruiting
-
Baylor College of MedicineNational Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)Recruiting
-
University of California, Los AngelesUnknownSepsis | Systemic Inflammatory Response Syndrome | Necrotizing Enterocolitis | Retinopathy of Prematurity | Bronchopulmonary DysplasiaUnited States